clinical pearl btk inhibitors and pirtobrutinib
Published 1 year ago • 50 plays • Length 25:18Download video MP4
Download video MP3
Similar videos
-
1:18
pirtobrutinib: the next generation of btk inhibitors
-
2:57
second-generation btk inhibitors and their clinical impact
-
1:26
combining btk and bcl-2 inhibitors for the treatment of cll
-
1:27
advances in btk and bcl2 inhibitors for cll
-
7:36
btki inhibitors in the treatment of b-cell lymphoma - martin dreyling session
-
2:12
phase iii combi-d study of dabrafenib and trametinib in patients with melanoma
-
2:16
dr. ruan discusses btk inhibitors in mcl
-
1:06
managing cardiac toxicities associated with btk inhibitors and selecting between these agents
-
1:01
btk inhibitors: toxicity, resistance, and combinations
-
8:20
btki inhibitors in the treatment of b-cell lymphoma - deborah stephens session
-
5:44
btk inhibitors as treatment for b-cell lymphomas
-
1:32
selecting btk inhibitors for patients with mcl
-
47:59
advances and challenges in targeting kinases in cancer therapeutics
-
7:17
the future of btk inhibition in b-cell lymphomas
-
2:12
car-t therapy vs btk inhibitors in cll treatment
-
2:33
btki resistance and it's management
-
5:35
selecting a btk inhibitor for mantle cell lymphoma
-
1:16
dr. patel on differences between btk inhibitors in mcl